PHI Stock Overview
Phase Holographic Imaging PHI AB (publ) develops and markets instrumentation for non-invasive time-lapse imaging in Sweden and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 1/6 |
| Dividends | 0/6 |
Phase Holographic Imaging PHI AB (publ) Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | kr6.46 |
| 52 Week High | kr9.00 |
| 52 Week Low | kr3.90 |
| Beta | 1.05 |
| 1 Month Change | 0% |
| 3 Month Change | 14.95% |
| 1 Year Change | 70.00% |
| 3 Year Change | -74.72% |
| 5 Year Change | -77.61% |
| Change since IPO | -56.93% |
Recent News & Updates
Recent updates
Phase Holographic Imaging PHI (NGM:PHI) Is Making Moderate Use Of Debt
Nov 07
Phase Holographic Imaging PHI (NGM:PHI) Is Carrying A Fair Bit Of Debt
Jul 25Here's Why Phase Holographic Imaging PHI (NGM:PHI) Can Afford Some Debt
Apr 07Is Phase Holographic Imaging PHI (NGM:PHI) Using Debt In A Risky Way?
Oct 12Here's Why Phase Holographic Imaging PHI (NGM:PHI) Can Afford Some Debt
Oct 07Shareholder Returns
| PHI | SE Medical Equipment | SE Market | |
|---|---|---|---|
| 7D | 0% | -2.0% | -1.6% |
| 1Y | 70.0% | -8.7% | 8.5% |
Return vs Industry: PHI exceeded the Swedish Medical Equipment industry which returned -9.6% over the past year.
Return vs Market: PHI exceeded the Swedish Market which returned 8.2% over the past year.
Price Volatility
| PHI volatility | |
|---|---|
| PHI Average Weekly Movement | n/a |
| Medical Equipment Industry Average Movement | 7.2% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in SE Market | 13.2% |
| 10% least volatile stocks in SE Market | 3.4% |
Stable Share Price: PHI has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine PHI's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1997 | 13 | Patrik Eschricht | www.phiab.se |
Phase Holographic Imaging PHI AB (publ) develops and markets instrumentation for non-invasive time-lapse imaging in Sweden and internationally. The company’s products include HoloMonitor M4, a live cell imaging microscope system; HoloMonitor M3, a bench-top time-lapse cytometer equipped with a motorized stage and variable magnification; HoloMonitor app Suite for cell imaging software facilitates kinetic live-cell tracking and analysis; HoloMonitor M4FL, a system for fluorescence; and HoloMonitor single tracking, kinetic dose response and cell mobility, cell morphology, wound healing, cell quality control, cell control, and kinetic cell proliferation assay. It offers HoloLids to eliminate image disturbances caused by surface vibrations and condensation inside the cell culture vessel; Vessel Holder to fix the culture vessel to the motorized stage; and HoloDry to keep optics for condensation of HoloMonitor free.
Phase Holographic Imaging PHI AB (publ) Fundamentals Summary
| PHI fundamental statistics | |
|---|---|
| Market cap | kr169.21m |
| Earnings (TTM) | -kr22.54m |
| Revenue (TTM) | kr10.69m |
15.8x
P/S Ratio-7.5x
P/E RatioIs PHI overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| PHI income statement (TTM) | |
|---|---|
| Revenue | kr10.69m |
| Cost of Revenue | kr3.68m |
| Gross Profit | kr7.01m |
| Other Expenses | kr29.55m |
| Earnings | -kr22.54m |
Last Reported Earnings
Jan 31, 2024
Next Earnings Date
Jun 26, 2024
| Earnings per share (EPS) | -0.86 |
| Gross Margin | 65.56% |
| Net Profit Margin | -210.82% |
| Debt/Equity Ratio | 167.0% |
How did PHI perform over the long term?
See historical performance and comparison